Rankings
▼
Calendar
HRMY FY 2024 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
HRMY
Harmony Biosciences Holdings, Inc.
$2B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$715M
+22.8% YoY
Gross Profit
$558M
78.1% margin
Operating Income
$191M
26.7% margin
Net Income
$145M
20.4% margin
EPS (Diluted)
$2.51
Cash Flow
Operating Cash Flow
$220M
Free Cash Flow
$219M
Stock-Based Comp.
$43M
Balance Sheet
Total Assets
$999M
Total Liabilities
$340M
Stockholders' Equity
$659M
Cash & Equivalents
$453M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$715M
$582M
+22.8%
Gross Profit
$558M
$461M
+21.1%
Operating Income
$191M
$192M
-0.6%
Net Income
$145M
$129M
+12.9%
← Q4 2023
All Quarters
Q1 2024 →